GlassScriptPhysician profile
Lisa M Wallace
NPI 1235637182
$7,304.66
in general payments reported to CMS, 2019-2025
54 companies · $1,443 in 2025
The $1,443 reported for 2025 was more than what 92% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $574 · 2022: $2,076 · 2023: $1,534 · 2024: $1,679 · 2025: $1,443.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,655.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,655.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $792.25 | 2021-2025 | |
| Novo Nordisk INC | $731.31 | 2021-2025 | Wegovy, Saxenda, Ozempic |
| Astrazeneca Pharmaceuticals LP | $583.44 | 2021-2025 | Airsupra, Farxiga, Breztri |
| Glaxosmithkline, LLC. | $568.15 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Pfizer INC. | $565.73 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $366.68 | 2022-2025 | Jardiance, Synjardy, Tradjenta |
| Amgen INC. | $347.91 | 2022-2025 | Evenity, Prolia, Repatha |
| Novartis Pharmaceuticals Corporation | $286.49 | 2021-2025 | |
| Abbott Laboratories | $269.38 | 2021-2025 | Cardiomems, Freestyle Libre 3 |
| Lilly USA, LLC | $223.37 | 2021-2025 | Zepbound, Mounjaro, Jardiance |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $204.72 | 2021-2024 | Xifaxan, Trulance |
| Esperion Therapeutics, INC. | $161.39 | 2021-2025 | Nexletol |
| Sumitomo Pharma America, INC. | $150.17 | 2023-2025 | Gemtesa |
| Merck Sharp & Dohme LLC | $145.82 | 2021-2025 | Capvaxive, Gardasil 9, Gardasil |
| Biohaven Pharmaceutical Holding Company LTD. | $123.37 | 2022 |
Show all 54 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $110.00 | 2023 | Azure Xt Dr Mri Surescan |
| Janssen Pharmaceuticals, INC | $108.01 | 2022-2024 | Xarelto |
| Exact Sciences Corporation | $106.57 | 2023-2025 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $105.94 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $88.75 | 2022-2024 | Eliquis |
| Daiichi Sankyo INC. | $82.19 | 2023-2024 | Injectafer |
| Corcept Therapeutics | $81.37 | 2024-2025 | Korlym |
| Ironwood Pharmaceuticals, INC | $77.71 | 2022-2024 | Linzess |
| Sunovion Pharmaceuticals INC. | $74.96 | 2022 | |
| Dexcom, INC. | $72.77 | 2022-2025 | Dexcom G6 Transmitter |
| Takeda Pharmaceuticals U.S.A., INC. | $71.39 | 2021-2022 | |
| Antares Pharma, INC. | $68.68 | 2022-2024 | Xyosted |
| Boston Scientific Corporation | $55.23 | 2023-2025 | Watchman Flx |
| Seqirus USA INC | $55.05 | 2022-2025 | Flucelvax, Fluad, Flucelvax Quadrivalent |
| Nevro Corp. | $52.33 | 2023-2024 | Senza |
| Axsome Therapeutics, INC. | $51.59 | 2024-2025 | Auvelity |
| Amarin Pharma, INC. | $50.79 | 2022 | |
| Sanofi-Aventis U.S. LLC | $46.57 | 2022-2023 | |
| Sanofi Pasteur INC. | $46.00 | 2024-2025 | |
| Shield Therapeutics INC | $30.63 | 2022-2024 | |
| Biohaven Pharmaceuticals, INC. | $30.38 | 2021 | |
| Phathom Pharmaceuticals, INC. | $28.61 | 2025 | Voquezna |
| Vistapharm, INC. | $26.15 | 2021 | |
| Novavax INC | $25.07 | 2023 | Novavax Covid-19 Vaccine, Adjuvanted |
| Xeris Pharmaceuticals, INC. | $24.93 | 2023 | Gvoke Hypopen |
| Hologic Sales and Service, LLC | $21.35 | 2022 | |
| United Therapeutics Corporation | $20.77 | 2025 | Steen Solution |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $18.36 | 2025 | Caplyta |
| Impel Pharmaceuticals INC. | $18.33 | 2022 | |
| Corium, LLC | $17.86 | 2023 | Adlarity |
| Otsuka America Pharmaceutical, INC. | $16.61 | 2022 | |
| Dynavax Technologies Corporation | $16.34 | 2024 | Heplisav-B |
| Purdue Pharma L.P. | $16.21 | 2025 | Nalmefene Hydrochloride |
| Halozyme INC | $14.20 | 2023 | |
| Teva Pharmaceuticals USA, INC. | $12.77 | 2022 | |
| Nestle Healthcare Nutrition INC. | $11.67 | 2021 | |
| Currax Pharmaceuticals LLC | $11.42 | 2021 | |
| Cashflow Solutions, LLC | $9.42 | 2024 | Pcd-52 737a (US) White, Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt |
| Cequr Corporation | $7.50 | 2025 | Cequr Simplicity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Wallace listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.